Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro

doi:10.3748/wjg.v8.i2.253

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2524)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

264

HTML

2077

Figures (1-5)

183

Sum=2524

Apr 15, 2002 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Apr 15, 2002; 8(2): 253-257
Published online Apr 15, 2002. doi: 10.3748/wjg.v8.i2.253

Full Size Figure Download Figure

Figure 3 Expression of human endostatin-HA fusion protein in endostatin-transfected cells. Anti-HA monocolonal antibody was applied to SMMC7721 transferred with pLncx; A: and SMMC7721 transferred with pLncx-endo; B: followed by a HRP-conjugated secondary antibody. Hematoxylin counterstain. × 400.

Citation: Wang X, Liu FK, Li X, Li JS, Xu GX. Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro. World J Gastroenterol 2002; 8(2): 253-257
URL: https://www.wjgnet.com/1007-9327/full/v8/i2/253.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i2.253